Overview
- Defense Secretary Pete Hegseth announced a program on July 15 that mandates yearly testosterone tests for all service members aged 30 and older and offers voluntary testosterone therapy to those with low results.
- U.S. District Judge Ana Reyes has formally noticed the program in the lawsuit over the transgender ban and ordered the government to explain why the same hormone treatment would be readiness-enhancing for some troops but disqualifying for others.
- Medical experts and professional societies have warned that routine population screening departs from standard practice, which calls for symptom-driven repeat morning tests before prescribing testosterone and for careful follow-up.
- The Pentagon has not published key implementation details such as diagnostic thresholds, monitoring rules, deployability criteria, or cost estimates, leaving operational and equity questions unanswered for service members.
- The announcement clashes with the administration’s early-2025 policy that cited hormone care as a readiness burden and has heightened legal and political scrutiny as courts set an expedited discovery schedule toward an early‑2027 trial.